Development of AEZS-115 (ZEN-019) by optimization of structurally unique, orally active, peptidomimetic GnRH antagonists.
Paulini
K W
KW
AEterna Zentaris GmbH, Discovery and Preclinical Development, Weismuellerstr. 50, 60314 Frankfurt am Main, Germany.
Baasner
S
S
Gerlach
M
M
Polymeropoulos
E E
EE
Schmidt
P
P
Schuster
T
T
Teifel
M
M
Guenther
E G
EG
D000284:Administration, Oral; D000818:Animals; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006168:Guinea Pigs; D008297:Male; D015394:Molecular Structure; D051381:Rats
D007987:Gonadotropin-Releasing Hormone